An open-label analyze was completed in 2016 in the united kingdom to investigate the feasibility, safety and efficacy of psilocybin in managing people with unipolar treatment-resistant depression with promising results; Even though the examine was smaller and concerned only twelve sufferers, 7 of These people achieved official criteria for remissio